After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that MDXG: Axiofill Update & Series B Conversion.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Mimedx Group Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $8.14 and fluctuated between $8.32 as its day high and $8.00 as its day low. The current market capitalization of Mimedx Group Inc is $947.33M. A total of 0.66 million shares were traded on the day, compared to an average of 671.51K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, MDXG has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 28,195,249 and the disposition of 0 shares. Over the last 12 months, there were 16 BUYs and 22 SELLs from insiders. Insiders purchased 29,567,698 shares during that period but sold 203,328.
In the most recent transaction, DOUG RICE bought 5,000 shares of MDXG for 7.16 per share on Nov 21. After the transaction, the Chief Financial Officer now owns 102,200 company shares. In a previous transaction on May 16, Stein Robert Benjamin sold 10,365 shares at 5.95 per share. MDXG shares that President, Regenerative Med. owns now total 317,803.
Among the insiders who sold shares, Stein Robert Benjamin disposed of 3,607 shares on May 15 at a per-share price of $6.15. This resulted in the President, Regenerative Med. holding 328,168 shares of MDXG after the transaction. In another insider transaction, Carlson Peter M sold 5,976 shares at $5.93 per share on May 10. Company shares held by the Chief Financial Officer now total 656,435.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for MDXG in the last 3 months, the mean price target is $11.85 with high estimates of $13.00 and low estimates of $11.00. In terms of 52-week highs and lows, MDXG has a high of $9.27 and a low of $3.08.
As of this writing, MDXG has an earnings estimate of $0.07 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.08 per share and a lower estimate of $0.06. The company reported an EPS of $0 in the last quarter, which was 100.00% higher than expectations of -$0.02.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MDXG’s latest balance sheet shows that the firm has $87.08M in Cash & Short Term Investments as of fiscal 2021. There were $48.13M in debt and $42.36M in liabilities at the time. Its Book Value Per Share was $0.01, while its Total Shareholder’s Equity was $82.00k.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDXG is Buy with a score of 5.00.
